Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis CapabilitiesBusiness Wire • 10/21/20
Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and WebcastBusiness Wire • 10/20/20
Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR SystemBusiness Wire • 10/19/20
Bruker Introduces PaSER™ Software for ‘Run and Done' 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 AwardBusiness Wire • 10/19/20
Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational StudiesBusiness Wire • 09/30/20
Bruker Corporation to Participate in the 2020 Wells Fargo Virtual Healthcare ConferenceBusiness Wire • 09/04/20
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and ProteinsBusiness Wire • 08/10/20
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass SpectrometryBusiness Wire • 08/07/20
Bruker Corporation (BRKR) CEO Frank Laukien on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/04/20
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule ApplicationsBusiness Wire • 07/30/20
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in EuropeBusiness Wire • 07/27/20
Bruker Announces Date and Time of Second Quarter 2020 Earnings Release and WebcastBusiness Wire • 07/20/20